Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia von Stone, R M, Fischer, T, Paquette, R, Schiller, G, Schiffer, C A, Ehninger, G, Cortes, J, Kantarjian, H M, DeAngelo, D J, Huntsman-Labed, A, Dutreix, C, del Corral, A, Giles, F

Volltext

Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib von Hochhaus, A, Baccarani, M, Deininger, M, Apperley, J F, Lipton, J H, Goldberg, S L, Corm, S, Shah, N P, Cervantes, F, Silver, R T, Niederwieser, D, Stone, R M, Dombret, H, Larson, R A, Roy, L, Hughes, T, Müller, M C, Ezzeddine, R, Countouriotis, A M, Kantarjian, H M

Volltext

KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells von Etchin, J, Berezovskaya, A, Conway, A S, Galinsky, I A, Stone, R M, Baloglu, E, Senapedis, W, Landesman, Y, Kauffman, M, Shacham, S, Wang, J C Y, Look, A T

Volltext

An Inherited Genetic Variant in CEP72 Promoter Predisposes to Vincristine‐Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia von Stock, W, Diouf, B, Crews, KR, Pei, D, Cheng, C, Laumann, K, Mandrekar, SJ, Luger, S, Advani, A, Stone, RM, Larson, RA, Evans, WE

Volltext

Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice von Etchin, J, Montero, J, Berezovskaya, A, Le, B T, Kentsis, A, Christie, A L, Conway, A S, Chen, W C, Reed, C, Mansour, M R, Ng, C E L, Adamia, S, Rodig, S J, Galinsky, I A, Stone, R M, Klebanov, B, Landesman, Y, Kauffman, M, Shacham, S, Kung, A L, Wang, J C Y, Letai, A, Look, A T

Volltext

A rational vaccine pipeline for tuberculosis [State of the art series. New tools. Number 5 in the series] von Brennan, M. J., Stone, M. R., Evans, T.

Volltext

United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia von SOIGNET, Steven L, FRANKEL, Stanley R, SIEVERS, Eric L, COUTRE, Steven, DAHLBERG, Steve, ELLISON, Ralph, WARRELL, Raymond P, DOUER, Dan, TALLMAN, Martin S, KANTARJIAN, Hagop, CALLEJA, Elizabeth, STONE, Richard M, KALAYCIO, Matt, SCHEINBERG, David A, STEINHERZ, Peter

Volltext

Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome von SEKERES, M. A, STONE, R. M, ZAHRIEH, D, NEUBERG, D, MORRISON, V, DE ANGELO, D. J, GALINSKY, I, LEE, S. J

Volltext

A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid... von Metzeler, K H, Maharry, K, Kohlschmidt, J, Volinia, S, Mrózek, K, Becker, H, Nicolet, D, Whitman, S P, Mendler, J H, Schwind, S, Eisfeld, A-K, Wu, Y-Z, Powell, B L, Carter, T H, Wetzler, M, Kolitz, J E, Baer, M R, Carroll, A J, Stone, R M, Caligiuri, M A, Marcucci, G, Bloomfield, C D

Volltext

Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720 von Baer, M R, George, S L, Sanford, B L, Mrózek, K, Kolitz, J E, Moore, J O, Stone, R M, Powell, B L, Caligiuri, M A, Bloomfield, C D, Larson, R A

Volltext

Report of an international working group to standardize response criteria for myelodysplastic syndromes von Cheson, Bruce D., Bennett, John M., Kantarjian, Hagop, Pinto, Antonio, Schiffer, Charles A., Nimer, Stephen D., Löwenberg, Bob, Beran, Miroslav, de Witte, Theo M., Stone, Richard M., Mittelman, Moshe, Sanz, Guillermo F., Wijermans, Pierre W., Gore, Steven, Greenberg, Peter L.

Volltext

Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia von DeAngelo, D J, Stevenson, K E, Dahlberg, S E, Silverman, L B, Couban, S, Supko, J G, Amrein, P C, Ballen, K K, Seftel, M D, Turner, A R, Leber, B, Howson-Jan, K, Kelly, K, Cohen, S, Matthews, J H, Savoie, L, Wadleigh, M, Sirulnik, L A, Galinsky, I, Neuberg, D S, Sallan, S E, Stone, R M

Volltext

Clinical features and gene- and microRNA-expression patterns in adult acute leukemia patients with t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3) von Bhatnagar, B, Blachly, J S, Kohlschmidt, J, Eisfeld, A-K, Volinia, S, Nicolet, D, Carroll, A J, Block, A W, Kolitz, J E, Stone, R M, Mrózek, K, Byrd, J C, Bloomfield, C D

Volltext

The Difficult Problem of Acute Myeloid Leukemia in the Older Adult von Stone, Richard M

Volltext

Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503) von Blum, W, Sanford, B L, Klisovic, R, DeAngelo, D J, Uy, G, Powell, B L, Stock, W, Baer, M R, Kolitz, J E, Wang, E S, Hoke, E, Mrózek, K, Kohlschmidt, J, Bloomfield, C D, Geyer, S, Marcucci, G, Stone, R M, Larson, R A

Volltext

The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia von Eisfeld, A-K, Mrózek, K, Kohlschmidt, J, Nicolet, D, Orwick, S, Walker, C J, Kroll, K W, Blachly, J S, Carroll, A J, Kolitz, J E, Powell, B L, Wang, E S, Stone, R M, de la Chapelle, A, Byrd, J C, Bloomfield, C D

Volltext

KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32) von LEVINE, R. L, WADLEIGH, M, STERNBERG, D. W, WLODARSKA, I, GALINSKY, I, STONE, R. M, DEANGELO, D. J, GILLILAND, D. Gary, COOLS, J

Volltext

Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia von Eisfeld, A-K, Kohlschmidt, J, Schwind, S, Nicolet, D, Blachly, J S, Orwick, S, Shah, C, Bainazar, M, Kroll, K W, Walker, C J, Carroll, A J, Powell, B L, Stone, R M, Kolitz, J E, Baer, M R, de la Chapelle, A, Mrózek, K, Byrd, J C, Bloomfield, C D

Volltext

Somatic mutational landscape of AML with inv(16) or t(8;21) identifies patterns of clonal evolution in relapse leukemia von Sood, R, Hansen, N F, Donovan, F X, Carrington, B, Bucci, D, Maskeri, B, Young, A, Trivedi, N S, Kohlschmidt, J, Stone, R M, Caligiuri, M A, Chandrasekharappa, S C, Marcucci, G, Mullikin, J C, Bloomfield, C D, Liu, P

Volltext

Pathological glycogenesis through glycogen synthase 1 and suppression of excessive AMP kinase activity in myeloid leukemia cells von Bhanot, H, Reddy, M M, Nonami, A, Weisberg, E L, Bonal, D, Kirschmeier, P T, Salgia, S, Podar, K, Galinsky, I, Chowdary, T K, Neuberg, D, Tonon, G, Stone, R M, Asara, J, Griffin, J D, Sattler, M

Volltext